SLC1A2 and myeloid sarcoma: It is well-established that excessive activation of the glutamatergic pathway plays an important role in the pathophysiology of MS; therefore, by enhancing the GLT1 expression, beta-lactam antibiotics might offer some degree of neuroprotection.